SCHEMBL8501924

SCHEMBL8501924

Clc1ccc(-c2cnc3cc(-c4ccncc4)ccc3n2)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.43
PIK3CD O00329 2/20 0.43
PIK3CB P42338 2/20 0.43
PIK3CG P48736 2/20 0.43
LRRK2 Q5S007 2/20 0.43
MAP4K4 O95819 1/20 0.43
CDK8 P49336 1/20 0.43
CLK2 P49760 1/20 0.43
CDK7 P50613 1/20 0.43
CDK9 P50750 1/20 0.43
CDK5 Q00535 1/20 0.43
ACVR1 Q04771 1/20 0.43
ROCK1 Q13464 1/20 0.43
DYRK1A Q13627 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
DYRK1B Q9Y463 1/20 0.43
PDGFRB P09619 4/20 0.43
PDGFRA P16234 4/20 0.43
HSD17B1 P14061 3/20 0.42
HSD17B2 P37059 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8502771 0.95 PIK3CA (0.43) PIK3CAPIK3CDPIK3CBPIK3CGLRRK2
SCHEMBL15669402 0.81 MAP4K4 (0.54) PIK3CAPIK3CDPIK3CBPIK3CGLRRK2
SCHEMBL8562276 0.80 CYP2A6 (0.47) PDGFRBPDGFRAHSD17B1HSD17B2KDM4E
SCHEMBL28321229 0.76 MAP4K4 (0.53) PIK3CAPIK3CDPIK3CBPIK3CGLRRK2
SCHEMBL8502649 0.75 NPC1 (0.46) PIK3CAPIK3CDPIK3CBPIK3CGLRRK2
SCHEMBL8887646 0.71 NPC1 (0.56) PDGFRBPDGFRAHSD17B1HSD17B2KDM4E
SCHEMBL8500901 0.70 PDGFRB (0.71) PDGFRBPDGFRAKDM4EMAPTNPC1
Hydrochloric Acid SCHEMBL8562915 0.69 PDGFRB (0.69) PDGFRBPDGFRAKDM4EMAPTNPC1
SCHEMBL8499837 0.69 PDGFRB (0.53) PDGFRBPDGFRAKDM4EHSD17B10LMNA
SCHEMBL6617109 0.68 PDGFRB (0.40) ROCK1DYRK1APDGFRBPDGFRAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed